Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,564Revenue (TTM) $M1,338Net Margin (%)5.9Altman Z-Score3.3
Enterprise Value $M7,099EPS (TTM) $0.3Operating Margin %7.2Piotroski F-Score4
P/E(ttm)82.8Beneish M-Score-2.8Pre-tax Margin (%)4.1Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %2.9Quick Ratio2.9Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %1.8Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow26.1y-y EBITDA Growth Rate %-15.1ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %--PEG46.0ROE % (ttm)3.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M226ROIC % (ttm)2.9Gross Margin Increase y-yN

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

QGEN is held by these investors:



QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

Quarterly/Annual Reports about QGEN:

    News about QGEN:

    Articles On GuruFocus.com
    David Herro's Oakmark International Small Cap Fund 4th Quarter Commentary Jan 08 2016 
    Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
    Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
    Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 

    More From Other Websites
    New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to... Feb 16 2017
    QIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 Feb 08 2017
    QIAGEN NV :QGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017 Feb 06 2017
    QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4 Feb 03 2017
    Edited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT Feb 02 2017
    Qiagen meets 4Q profit forecasts Feb 01 2017
    Qiagen meets 4Q profit forecasts Feb 01 2017
    QIAGEN Reports Results for Fourth Quarter and Full-year 2016 Feb 01 2017
    QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : February 1, 2017 Feb 01 2017
    Q4 2016 Qiagen NV Earnings Release - 4:00 pm ET Feb 01 2017
    QIAGEN Hereditary and Rare Disease Solution Chosen by Genomics England Jan 30 2017
    QIAGEN's QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits Jan 26 2017
    QIAGEN Announces Adjustment of Conversion Ratio Under its 0.375% Senior Unsecured Convertible Notes... Jan 26 2017
    QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017 Jan 19 2017
    QIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase Jan 18 2017
    QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : January 18, 2017 Jan 18 2017
    QIAGEN N.V. to Report Fourth Quarter and Full Year of 2016 Results Jan 18 2017
    Singulex Enters into Collaboration with QIAGEN to Develop Companion Diagnostics Jan 10 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)